Friederike is the scientific Director on the Blue Horizon Investing Team, and a board member at Core Biogenesis and Cubiq Foods. She brings experience in biotechnology and strategy consulting: Friederike holds a PhD in Plant Biotechnology from the University of Oxford. With that, she joined the Boston Consulting Group, working across biopharma, biotech, energy and private equity for 3.5 years.

Friederike maintains a strong network in the scientific community, and is excited about safeguarding humanity’s long-term future. To this end, she co-authored work that informed the research agenda of Oxford’s Global Priorities Institute, and is an active member of the effective altruism community.

Friederike Grosse-Holz

Scientific Director

Blue Horizon

LinkedIn picto

Also speaking:

  • Virginia Puzzolo, Head of CBE JU Programme Unit, CBE JU
  • Michael Brandkamp, Managing Partner, European Circular Bioeconomy Fund
  • Seren Kell, Science and Technology Manager, The Good Food Institute Europe
  • Elke Duwenig, Senior Biotechnology Expert Global Regulatory/Public & Government Affairs, Nutrition & Health, BASF SE